только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 34 / 36
Страница 1 / 1

Литература

  1. Костинов А. М., Костинов М. П., Машилов К. В. Пневмококковые вакцины и COVID-19 — антагонизм. Медицинский совет. 2020;(17):66-73. doi:10.21518/2079-701X-2020-17-66-73.
  2. Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1,590 patients with Covid-19 in China: A nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020.
  3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/ S0140-6736(20)30211-7.
  4. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel CoronavirusInfected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi:10.1001/ jama.2020.1585.
  5. Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53(4):505-12. doi:10.1016/j. jmii.2020.05.013.
  6. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths Robert Root-Bernstein Vaccines (Basel) 2021;9(5):474. doi:10.3390/vaccines9050474.
  7. Gaviria-Agudelo CL, Jordan-Villegas A, Garcia C, McCracken GH, Jr. The effect of 13-valent pneumococcal conjugate vaccine on the serotype distribution and antibiotic resistance Profiles in children with invasive pneumococcal disease. J Pediatric Infect Dis Soc. 2017;6:253-9.
  8. Herrera AL, Huber VC, Chaussee MS. The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections. Front. Microbiol. 2016;7:342. doi:10.3389/fmicb.2016.00342.
  9. Root-Bernstein RS, Podufaly A, Aimone F. Antigenic complementarity between influenza a virus and Haemophilus influenzae may drive lethal co-infection such as that seen in 1918-19. J. Virol. Antivir. Res. 2013;2:1. doi:10.4172/2324-8955.1000104.
  10. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pan-demic influenza: Implications for pandemic influenza preparedness. J. Infect. Dis. 2008;198:962. doi:10.1086/591708.
  11. Miellet WR, Van Veldhuizen J, Nicolaie AM, et al. Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults. Clin. Infect. Dis. 2020;30. doi:10.1093/cid/ciaa1551.
  12. Chen X, Liao B, Cheng L, et al. The microbial coinfection in COVID-19. Appl. Microbiol. Biotechnol. 2020;104:1-9. doi:10.1007/s00253-020-10814-6.
  13. Intra J, Sarto C, Beck E, et al. Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected. Am. J. Infect. Control. 2020;48:1130-1. doi:10.1016/j.ajic.2020.06.185.
  14. Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: A systematic review and meta-analysis. Influ. Respir. Viruses. 2016;10:394-403. doi:10.1111/irv.12398.
  15. Lv Z, Cheng S, Le J, et al. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: A retrospective cohort study. Microbes Infect. 2020;22:195-9. doi:10.1016/j. micinf.2020.05.007.
  16. Cucchiari D, Pericàs JM, Riera J, et al. Pneumococcal superinfection in COVID-19 patients: A series of 5 cases. Med. Clínica. 2020;155:502-5. doi:10.1016/j.medcli.2020.05.022.
  17. Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: A retrospective cohort study. Clin. Microbiol. Infect. 2021;27:83-8. doi:10.1016/j.cmi.2020.07.041.
  18. Contou D, Claudinon A, Pajot O, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann. Intensiv. Care. 2020;10:1-9. doi:10.1186/s13613-020-00736-x.
  19. Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005. doi:10.1016/j.virusres.2020.198005.
  20. Zhu, X, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285. doi:10.1016/j.virusres.2020.198005.
  21. Sharov KS. CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: Secondary bacterial pneumonia and viral co-infection. 2020;10(2). doi:10.7189/jogh.10.020504.
  22. Cortinovis M, Perico N, Remuzzi G. Long-term follow-up of recovered patients with COVID-19. Lancet. 2021;397:173-5. doi:10.1016/S0140-6736(21)00039-8.
  23. Fraser E. Long term respiratory complications of covid-19: substantial population morbidity is likely. BMJ. 2020;370:m3001. doi:10.1136/bmj.m3001.
  24. Guler SA, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57:2003690. doi:10.1183/13993003.03690-2020.
  25. Bellan M, Doddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID19 four months after hospital discharge. JAMA Network Open. 2021;4(1):e2036142. doi:10.1001/jamanetworkopen.2020.36142.
  26. Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology & mortality. Clin Infect Dis. 2017;65(11):1806-12.
  27. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71-9.
  28. Руководство ВОЗ “Руководство по плановой иммунизации во время пандемии COVID-19 в Европейском регионе ВОЗ”. http://www.euro.who.int/ru/health-topics/health-emergencies/coronaviruscovid-19/novel-coronavirus-2019-ncov-technical-guidance/coronavirus-disease-covid-19-outbreaktechnical-guidance-europe/guidance-on-routine-immunization-services-during-covid-19-pandemic-in-thewho-european-region-2020
  29. Методические рекомендации “Иммунизация взрослых”, МЗ РФ 2020, Драпкина О.М, Брико Н. И. http://nasci.ru/?id=19860&download=1
  30. Методические рекомендации по вакцинопрофилактике пневмококковой инфекции у детей. М.: коллектив экспертов под рук. акад. Л. С. Намазовой-Барановой. 2020.
  31. Приказ Министерства здравоохранения Российской Федерации от 06.12.2021 №1122н “Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям”
  32. Постановление Главного государственного санитарного врача Российской Федерации от 28.01.2021 № 4 “Об утверждении санитарных правил и норм СанПиН 3.3686-21 “Санитарно-эпидемиологические требования по профилактике инфекционных болезней”.
  33. Демко И. В., Корчагин Е. Е., Гордеева Н. В. и др. Опыт вакцинопрофилактики пневмококковой инфекции у взрослых на примере Красноярского края. Пульмонология. 2017;27(1):21-8. doi:10.18093/ 0869018920172712128.
  34. Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. 2009;374(9698):1339-50.